Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
日曜日, 9 06

Genmab AS

GMABNASDAQ
Trade with Public
Trade with Public
$33.60
-0.81-2.35%
近くで: Sep 4, 5:00 PM EST
$33.60
N/A
時間外: Sep 4, 4:00 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Genmab Financials

Genmab (GMAB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Genmab Raises FY2026 Sales Guidance from $4.065B-$4.395B to $4.325B-$4.525B vs $4.355B Est

Genmab (NASDAQ:GMAB) raises FY2026 sales outlook from $4.065 billion-$4.395 billion to $4.325 billion-$4.525 billion vs $4.355 billion estimate.
Benzinga Newsdesk

PRO
Genmab Affirms FY2026 Sales Guidance of $4.065B-$4.395B vs $4.300B Est

Genmab (NASDAQ:GMAB) affirms FY2026 sales outlook from $4.065 billion-$4.395 billion to $4.065 billion-$4.395 billion vs $4.300 billion estimate.
Benzinga Newsdesk

PRO
Genmab Q1 EPADS $0.083 Misses $0.17 Estimate, Sales $896.000M Beat $890.400M Estimate

Benzinga Newsdesk

PRO
Genmab Sees FY2026 Sales $4.065B-$4.395B vs $4.214B Est

Genmab (NASDAQ:GMAB) sees FY2026 sales of $4.065 billion-$4.395 billion vs $4.214 billion analyst estimate.
Benzinga Newsdesk

PRO
Genmab Q4 EPS $0.05 Misses $0.44 Estimate, Sales $1.058B Miss $4.401B Estimate

Genmab (NASDAQ:GMAB) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.44 by 88.64 percent. This is a 94.12 percent decrease over earnings of $0.85 per share from the same
Benzinga Newsdesk

Genmab: Q4 Earnings Insights

Benzinga Insights

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved